Has anyone used Naspm, (N-[3-[4-(3-aminopropylamino)butylamino]propyl]-2-naphthalen-1-ylacetamide;trihydrochloride) a calcium-permeable AMPA-receptors blocker, in the pipette internal solution?
Drug final concentration?
How long did it took to see the effect?
How the analysis was performed?
A good reference could be of great help.
Thanks!